The 11th call for the EU programme Innovative Medicines Initiative (IMI) was launched today. Of the eight topics, one is of particular interest for NNN members: European platform for proof of concept for prevention in Alzheimer’s Disease. 

The health cluster organisations Oslo Cancer Cluster, Oslo Medtech and Nansen Neuroscience Network propose the exploration of a new financial instrument to stimulate innovation in health care.   

The European initiative ERASysAPP is launching its first joint call to promote research projects that are application-oriented and/or industry-relevant.

Pre Diagnostics AS is a new Alzheimer’s disease (AD) diagnostics company based on Akershus University Hospital’s (AHUS) research. 

Our member company Smartfish was profiled in this Friday’s sports-extra of Finansavisen. 

NNN, The Norwegian Research Council, Oslo Medtech and Oslo Cancer Cluster hosted information meeting on Horizon 2020, IMI and AAL on November 25th. In Oslo Science Park Norwegian Research Council shared the latest on these programmes. 

The EU Joint Programme – Neurodegenerative Disease Research (JPND) is a global innovative research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND recently launched a pilot online partnering tool that was made available through the support of Nansen Neuroscience Network and the Norwegian software company Induct.

Fred Kavli, the philanthropist, physicist, entrepreneur, and the founder and chairman of the Kavli Foundation died on November 21st.